DOSSIER · 13F-HR · Q1 2026

Ishara Investments LP

$106M in tracked AUM across 37 positions as of Q1 2026.

II
CIK 0002111609 · last filed Mar 31, 2026
Total AUM
$106M
as of Q1 2026
Holdings
37
positions
Whale Score
54
54
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

Ishara Investments LP filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
PRAX
PRAXIS PRECISION MEDICINES I
$14M43K13.1%
02
AXSM
AXSOME THERAPEUTICS INC.
$7M41K6.6%
03
XERS
XERIS BIOPHARMA HOLDINGS INC
$6M1.0M5.6%
04
KALV
KALVISTA PHARMACEUTICALS INC
$6M277K5.3%
05
FOLD
AMICUS THERAPEUTIC
$5M369K5.1%
06
BMRN
BIOMARIN PHARMACEUTICAL INC
$5M82K4.4%
07
VSTM
VERASTEM INC
$4M820K4.1%
08
RARE
ULTRAGENYX PHARMACEUTICAL IN
$4M174K3.5%
09
ARWR
ARROWHEAD PHARMACEUTICALS IN
$3M55K3.3%
10
PCVX
VAXCYTE INC
$3M57K3.2%

Filing history

2026Q1Mar 31
$106M 20.8%
37 positionsView →
2025Q4Dec 31
$87M
38 positionsView →